These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38709660)

  • 1. Evaluation of the Contrast Enhancement Performance of Gadopiclenol for Magnetic Resonance Angiography in Healthy Rabbits and Pigs.
    Hugon G; Adriaensen H; Wintrebert M; Arnould L; Serfaty JM; Robert P
    Invest Radiol; 2024 Sep; 59(9):614-621. PubMed ID: 38709660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model.
    Robert P; Vives V; Grindel AL; Kremer S; Bierry G; Louin G; Ballet S; Corot C
    Radiology; 2020 Jan; 294(1):117-126. PubMed ID: 31660804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced magnetic resonance angiography: evaluation of the high relaxivity low diffusible gadolinium-based contrast agent P846 in comparison with gadoterate meglumine in rabbits at 1.5 Tesla and 3.0 Tesla.
    Peldschus K; Hamdorf M; Robert P; Port M; Graessner J; Adam G; Herborn CU
    Invest Radiol; 2008 Dec; 43(12):837-42. PubMed ID: 19002055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic and static magnetic resonance angiography of the supra-aortic vessels at 3.0 T: intraindividual comparison of gadobutrol, gadobenate dimeglumine, and gadoterate meglumine at equimolar dose.
    Kramer JH; Arnoldi E; François CJ; Wentland AL; Nikolaou K; Wintersperger BJ; Grist TM
    Invest Radiol; 2013 Mar; 48(3):121-8. PubMed ID: 23211552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Gadopiclenol and P846, 2 High-Relaxivity Macrocyclic Magnetic Resonance Contrast Agents Without Protein Binding, in a Rodent Model of Hepatic Metastases: Potential Solutions for Improved Enhancement at Ultrahigh Field Strength.
    Fries P; Massmann A; Robert P; Corot C; Laschke MW; Schneider G; Buecker A; Müller A
    Invest Radiol; 2019 Sep; 54(9):549-558. PubMed ID: 31033675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced magnetic resonance angiography in rabbits: evaluation of the gadolinium-based agent p846 and the iron-based blood pool agent p904 in comparison with gadoterate meglumine.
    Kinner S; Maderwald S; Parohl N; Albert J; Corot C; Robert P; Barkhausen J; Vogt FM
    Invest Radiol; 2011 Aug; 46(8):524-9. PubMed ID: 21577130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR angiography of carotid artery aneurysms in a porcine model at 3 Tesla: comparison of two different macrocyclic gadolinium chelates and of dynamic and conventional techniques.
    Wuesten O; Morelli JN; Miller MW; Tuzun E; Lenox MW; Fossum TW; Trelles M; Cotes C; Krombach GA; Runge VM
    J Magn Reson Imaging; 2012 Nov; 36(5):1203-12. PubMed ID: 22826184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Brain Lesion Enhancement and Gadolinium Deposition in the Rat Brain: Comparison Between Gadopiclenol and Gadobenate Dimeglumine.
    Violas X; Rasschaert M; Santus R; Factor C; Corot C; Catoen S; Idée JM; Robert P
    Invest Radiol; 2022 Feb; 57(2):130-139. PubMed ID: 34411032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Brain Metastases by Contrast-Enhanced MRI: Comparison of Gadopiclenol and Gadobenate in a Mouse Model.
    Robert P; Vives V; Rasschaert M; Hao J; Soares M; Lemaître M; Dencausse A; Catoen S
    Invest Radiol; 2024 Feb; 59(2):131-139. PubMed ID: 37921777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
    Attenberger UI; Runge VM; Jackson CB; Baumann S; Birkemeier K; Michaely HJ; Schoenberg SO; Reiser MF; Wintersperger BJ
    Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced magnetic resonance angiography: P792 blood pool agent versus Gd-DOTA in rabbits at 3.0 T versus 1.5 T.
    Herborn CU; Watkins DM; Baumann S; Robert P; Corot C; Runge VM
    Invest Radiol; 2007 Sep; 42(9):622-8. PubMed ID: 17700277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Gadolinium Distribution of the New High-Relaxivity Gadolinium Chelate Gadopiclenol in a Rat Model of Severe Renal Failure.
    Fretellier N; Rasschaert M; Bocanegra J; Robert P; Factor C; Seron A; Idée JM; Corot C
    Invest Radiol; 2021 Dec; 56(12):826-836. PubMed ID: 34091462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR Angiography at 3 T of Peripheral Arterial Disease: A Randomized Prospective Comparison of Gadoterate Meglumine and Gadobutrol.
    Loewe C; Arnaiz J; Krause D; Marti-Bonmati L; Haneder S; Kramer U;
    AJR Am J Roentgenol; 2015 Jun; 204(6):1311-21. PubMed ID: 26001243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle.
    Schubert T; Motosugi U; Kinner S; Colgan TJ; Sharma SD; Hetzel S; Wells S; Campo CA; Reeder SB
    J Magn Reson Imaging; 2017 Jun; 45(6):1617-1626. PubMed ID: 27862577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extremely Small Pseudoparamagnetic Iron Oxide Nanoparticle as a Novel Blood Pool T1 Magnetic Resonance Contrast Agent for 3 T Whole-Heart Coronary Angiography in Canines: Comparison With Gadoterate Meglumine.
    Park EA; Lee W; So YH; Lee YS; Jeon BS; Choi KS; Kim EG; Myeong WJ
    Invest Radiol; 2017 Feb; 52(2):128-133. PubMed ID: 27977466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance evaluation of renal artery stenosis in a swine model: performance of low-dose gadobutrol versus gadoterate meglumine in comparison with digital subtraction intra-arterial catheter angiography.
    Morelli JN; Runge VM; Ai F; Zhang W; Li X; Schmitt P; McNeal G; Miller M; Lennox M; Wusten O; Schoenberg SO; Attenberger UI
    Invest Radiol; 2012 Jun; 47(6):376-82. PubMed ID: 22543971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Less is better? Intraindividual and interindividual comparison between 0.075 mmol/kg of gadobenate dimeglumine and 0.1 mmol/kg of gadoterate meglumine for cranial MRI.
    Khouri Chalouhi K; Papini GDE; Bandirali M; Sconfienza LM; Di Leo G; Sardanelli F
    Eur J Radiol; 2014 Jul; 83(7):1245-1249. PubMed ID: 24816087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal Enhancement and Enhancement Kinetics of Gadobutrol, Gadoteridol, and Gadoterate Meglumine in Various Body Regions: A Comparative Animal Study.
    Knobloch G; Frenzel T; Pietsch H; Jost G
    Invest Radiol; 2020 Jun; 55(6):367-373. PubMed ID: 31985602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced magnetic resonance angiography (MRA): evaluation of three different contrast agents at two different doses (0.05 and 0.1 mmol/kg) in pigs at 1.5 Tesla.
    Voth M; Michaely HJ; Schwenke C; Vos B; Pietsch H
    Eur Radiol; 2011 Feb; 21(2):337-44. PubMed ID: 20809127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement characteristics and impact on image quality of two gadolinium chelates at equimolar doses for time-resolved 3-Tesla MR-angiography of the calf station.
    Hansmann J; Michaely HJ; Morelli JN; Luckscheiter A; Schoenberg SO; Attenberger UI
    PLoS One; 2014; 9(6):e99079. PubMed ID: 24893292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.